Deutsche Out in German Deals
World Economy

Deutsche Out in German Deals

Deutsche Bank AG, traditionally the go-to lender in Europe’s largest economy, is the most notable absentee in the year’s largest takeover.
Germany’s biggest lender missed out on the advisory and top-tier financing roles on Bayer AG’s $62 billion bid for Monsanto Co., according to people with knowledge of the matter. The company chose to advise rival German chemicals giant BASF SE, which has studied but so far sat out the biggest-ever consolidation wave in the global crop chemicals and seeds industry, the people said, according to a Bloomberg report.
Because of the potential client conflict, Deutsche Bank didn’t join the more than a dozen lenders pitching at Bayer’s headquarters in Leverkusen for a financing role, the people said. In the end, the German company picked Goldman Sachs Group Inc., HSBC Holdings Plc and JPMorgan Chase & Co. to work alongside its main advisers, Bank of America Corp. and Credit Suisse Group AG, to secure $63 billion in short-term loans, said the people.
The miss comes at a time when Chief Executive Officer John Cryan faces the challenge of trying to maintain an edge over the competition while shrinking the investment bank and reorganizing staff. Cryan reshuffled top management with his strategic overhaul in October and split the securities unit into a trading division and a business, run by Jeff Urwin, advising clients on the sale of stock and bonds as well as mergers.

 Prestigious Deal
“It’s very unfortunate timing, because they are going to lose out on a very prestigious deal, a very prestigious piece of league table and presumably some very nice fees,” said Christopher Wheeler, a London-based analyst with Atlantic Equities LLP. “Clearly, these things do happen.”
Spokesmen for Deutsche Bank and Bayer declined to comment.
The absence on the Bayer deal has cost Deutsche Bank its top standing in a ranking of merger advisers in its home market. The firm slumped to No. 6 in deals involving German companies so far this year, the lowest since 2012, compared with its leading position in 2015 and 2014 and runner-up post in 2013, according to data compiled by Bloomberg.
In western Europe, Deutsche Bank is No. 7 in M&A so far this year, the lowest level since 2013, according to the data. Its position has been hurt by missing the two biggest deals, both in agricultural chemicals: Bayer-Monsanto as well as China National Chemical Corp.’s planned acquisition of Swiss rival Syngenta AG for more than $43 billion.
While the Frankfurt-based lender is sitting out the Bayer deal because of the potential conflict with Ludwigshafen-based BASF, rivals that worked on ChemChina’s takeover of Syngenta, including Goldman Sachs, HSBC and JPMorgan, secured a role on the financing.

Short URL : http://goo.gl/pLWJQe
  1. http://goo.gl/su9BNT
  • http://goo.gl/juByMs
  • http://goo.gl/0rncqM
  • http://goo.gl/8EZeZC
  • http://goo.gl/jxSs1W

You can also read ...

Philippines May Suspend Excise Taxes on Petroleum Products
The Philippine government will suspend the collection of...
Jordan Approves New IMF-Guided Tax Law
Jordan’s cabinet on Monday approved major IMF-guided proposals...
SBI Reports Record $1.1b Loss
State Bank of India reported a loss of Rs. 7,718 crore ($1.1...
At present, the majority of investments are still being done in oil-gas and traditional industries while there is still almost no SME sector in the country.
While Saudi Arabia’s latest budget figures show progress in...
US, China are nearing a deal to remove American sales ban against ZTE.
US President Donald Trump retreated from imposing tariffs on...
IHS Markit to  Buy Rival Ipreo  for $1.8 Billion
Data firm IHS Markit Ltd. said it will buy smaller rival Ipreo...
Dubai Bank to Buy Turkey’s Denizbank for $3.2 Billion
Dubai’s biggest lender the National Bank of Dubai has agreed...
Catalonia Main Risk to Spain Growth
The political situation in Catalonia is one of the main...